Arrowhead Research Corporation Reports Fiscal 2013 Fourth Quarter And Year-End Financial Results
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced financial results for its fiscal 2013 fourth quarter and year ended September 30, 2013. The company is hosting a conference call at 4:30 p.m. Eastern time to discuss results.
Help employers find you! Check out all the jobs and post your resume.